Cu + KPV Blend: What It Is and What It Does

What Cu + KPV Blend is

This blend combines GHK-Cu, the copper-binding tripeptide glycyl-histidyl-lysine, with KPV, the three-residue C-terminal fragment of alpha-melanocyte-stimulating hormone. Each is supplied as an analytical-grade reference material for laboratory research; the combination has not itself been studied and the evidence below is for the two components separately.

Where it comes from

GHK was identified in 1973 by Loren Pickart, who noticed that a factor in young human plasma changed how liver cells behaved and traced it to the tripeptide, which binds copper tightly. Its concentration in plasma falls with age, which drove decades of skin and repair research. KPV is the last three residues (Lys-Pro-Val) of alpha-MSH; researchers found in the 1990s that this fragment kept much of the parent hormone's anti-inflammatory activity while losing its pigmentation and appetite effects.

What it does — in plain terms

GHK-Cu is best known from skin and wound research, where it is studied for collagen production, remodelling and anti-inflammatory signalling, and more recently in lung-fibrosis models. KPV is studied almost entirely for inflammation: in animal models of colitis and oral mucositis it dampened inflammatory signalling without the hormonal effects of the full alpha-MSH molecule. Together they are two anti-inflammatory research tools with different mechanisms.

How it works

GHK-Cu carries copper into cells and tissues in a form they can use, and in cell and animal studies it shifts gene expression toward repair: more collagen and glycosaminoglycan production, modulated matrix-remodelling enzymes, and lower markers of oxidative stress and inflammation. Formulation studies in liposomes and microspheres look at how to get it through skin and into tissue.

KPV works differently. It reduces activation of NF-kB, a master switch for inflammatory genes, in epithelial and immune cells, and in colitis models it lowered inflammatory cytokines and tissue damage. A 2021 study delivered it in a hydrogel to oral mucosa.

Because the two act on different parts of the inflammatory and repair machinery, the blend puts two reference materials in one vial; no published study has tested them together, so any combined effect is an inference.

What the research shows

Both components have a genuine and mostly preclinical literature. GHK-Cu's is broad and includes a large body of cosmetic-formulation work as well as animal repair and lung models; KPV's is narrower and centred on inflammation in the gut and mouth. Neither has substantial human clinical-trial evidence, and the combination has none.

• Pharmaceutics, 2023 — studied GHK-Cu in liposomal formulations for skin, characterising stability and delivery of the copper peptide.
• Redox Biology, 2024 — examined GHK-Cu in models of lung inflammation and fibrosis, reporting effects on inflammatory and oxidative-stress markers.
• Journal of Orthopaedic Research, 2015 — reported that GHK-Cu influenced healing of the anterior cruciate ligament in a rat model.
• Inflammatory Bowel Diseases, 2008 — showed that the tripeptide KPV reduced intestinal inflammation in an animal model of colitis, with lower inflammatory signalling in the gut lining.
• Biomaterials Science, 2021 — delivered KPV in a hydrogel to study oral mucositis in an animal model, reporting reduced inflammation at the site.

What Cu + KPV Blend is studied for

Skin and wound research. GHK-Cu's largest literature: collagen and matrix production, remodelling, and formulation work on getting the peptide through skin.

Lung inflammation and fibrosis. Animal models in which GHK-Cu reduced inflammatory and oxidative markers and fibrotic change.

Intestinal inflammation. KPV's core evidence: colitis models in which the tripeptide lowered NF-kB-driven inflammation and tissue injury.

Oral mucositis. A hydrogel delivery study of KPV in an animal model of mucositis, reporting less inflammation at the mucosa.

Storage & handling

As a lyophilized (freeze-dried) powder the blend is most stable kept cold and dark, refrigerated or frozen for longer holds. Once reconstituted with bacteriostatic water it should be refrigerated at roughly 2-8 °C, kept out of light, and protected from repeated freeze-thaw cycles. The copper complex gives the reconstituted solution a faint blue tint.

Reconstitution reference

Standard laboratory reconstitution volumes for Cu + KPV Blend, from the VNG Reconstitution Sheet. See the full reconstitution guide for the method and concentration math.